Guardant Health
GH
#1174
Rank
HK$156.09 B
Marketcap
HK$1,177
Share price
-2.35%
Change (1 day)
188.17%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of March 2026 : HK$15.01 Billion

According to Guardant Health 's latest financial reports the company's total assets are HK$15.01 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2026)

Total assets by year

Year Total assets Change
2025-12-31HK$15.66 B35.84%
2024-12-31HK$11.53 B-17.33%
2023-12-31HK$13.95 B10.91%
2022-12-31HK$12.57 B-26.82%
2021-12-31HK$17.18 B-2.39%
2020-12-31HK$17.61 B134.93%
2019-12-31HK$7.49 B62.97%
2018-12-31HK$4.59 B71.68%
2017-12-31HK$2.67 B196.42%
2016-12-31HK$0.90 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
HK$26.34 B 75.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
HK$20.50 B 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA